Spike glycoprotein (S glycoprotein) | P0DTC2

Created: May 5, 2023, 9:33 p.m. at 21:33

Models Name Description GMQE QSQE Seq Id Coverage Range Method Resolution Oligo-state Ligands Found by Seq Similarity
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.69 0.89 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwn.1.B
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.69 0.89 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwn.1.C
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.69 0.89 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwo.1.A
Spike glycoprotein
SARS-CoV-2 spike protein RBD and P17 fab complex
 0.02 0.00 100.00 1.00 1-1273 EM 0.00 monomer HHblits 0.62
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 0.87 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 14 x NAG-NAG HHblits 0.62
7cwl.1.B
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.68 0.88 100.00 1.00 1-1273 EM 0.00 homo-trimer 27 x NAG HHblits 0.62
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 0.87 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 14 x NAG-NAG HHblits 0.62
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 0.86 100.00 1.00 1-1273 EM 0.00 homo-trimer 16 x NAG, 14 x NAG-NAG HHblits 0.62
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.69 100.00 1.00 1-1273 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwu.1.H
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.68 100.00 1.00 1-1273 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwu.1.I
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.69 100.00 1.00 1-1273 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG HHblits 0.62
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 100.00 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.62
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 100.00 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG HHblits 0.62
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.04 100.00 1.00 1-1273 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
 0.07 100.00 1.00 1-1273 EM 0.00 hetero-1-1-1-mer 5 x NAG HHblits 0.62
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.07 100.00 1.00 1-1273 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
 0.57 100.00 1.00 1-1273 EM 0.00 hetero-1-1-mer HHblits 0.62
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
 0.60 100.00 1.00 1-1273 EM 0.00 monomer HHblits 0.62
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
 0.60 100.00 1.00 1-1273 EM 0.00 hetero-1-1-mer HHblits 0.62
7f3q.1.A
Spike glycoprotein
SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab
 0.03 100.00 1.00 1-1273 EM 0.00 hetero-1-1-1-1-1-mer 1 x NAG, 1 x MES HHblits 0.62
8dt3.1.A
Spike glycoprotein
Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined)
 0.07 100.00 1.00 1-1273 EM 0.00 hetero-1-1-1-mer HHblits 0.62
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.10 100.00 1.00 1-1273 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN HHblits 0.62
6xra.1.B
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.10 100.00 1.00 1-1273 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN HHblits 0.62
6xra.1.C
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.10 100.00 1.00 1-1273 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN HHblits 0.62
✓
 6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.72 0.85 100.00 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN HHblits 0.62
6xr8.1.B
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.72 100.00 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN HHblits 0.62
6xr8.1.C
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.72 100.00 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN HHblits 0.62
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.66 99.92 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
6zwv.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.66 99.92 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
6zwv.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.66 99.92 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7krq.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7krq.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7krr.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.72 99.92 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7krs.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN HHblits 0.62
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.72 99.92 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7krs.1.B
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.72 99.92 1.00 1-1273 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN HHblits 0.62
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 1.00 1-1273 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN HHblits 0.62
7upy.1.C
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.72 99.92 1.00 1-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC HHblits 0.62
7upy.1.A
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.72 99.92 1.00 1-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC HHblits 0.62
7upy.1.B
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.73 99.92 1.00 1-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC HHblits 0.62
8gjm.1.A
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.72 99.92 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN HHblits 0.62
8gjm.1.C
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.70 99.92 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN HHblits 0.62
8gjm.1.B
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.72 99.92 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN HHblits 0.62
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7d00.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czp.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG HHblits 0.62
7czr.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czw.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
7czq.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czu.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7d0c.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7czt.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.62
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.66 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.62
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.70 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.62
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG HHblits 0.62
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.62
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czy.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
7dx5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 29 x NAG, 26 x NAG-NAG HHblits 0.62
7dx9.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx6.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx8.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7d03.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7dx9.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx3.1.A
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx0.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dwz.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.69 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czz.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAG HHblits 0.62
7czv.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czu.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czr.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.62
7dx6.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx3.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 29 x NAG, 26 x NAG-NAG HHblits 0.62
7dx0.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx8.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dx7.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7czr.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czt.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czq.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czz.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAG HHblits 0.62
7czs.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG HHblits 0.62
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7d0c.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czv.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 26 x NAG, 22 x NAG-NAG, 3 x NAG-NAG-NAG HHblits 0.62
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG HHblits 0.62
7czq.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A10
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7d03.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG HHblits 0.62
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7czs.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG HHblits 0.62
7d0b.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.62
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czu.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG HHblits 0.62
7czy.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2F11_2B
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG, 2 x NAG-NAG-NAG HHblits 0.62
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG HHblits 0.62
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.72 99.84 1.00 1-1273 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG HHblits 0.62
7dwy.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.72 99.84 1.00 1-1273 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG HHblits 0.62
7dwy.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.72 99.84 1.00 1-1273 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG HHblits 0.62
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.69 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dwx.1.J
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dx3.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and no PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dwx.1.G
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dx5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 29 x NAG, 26 x NAG-NAG HHblits 0.62
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx6.1.C
Spike glycoprotein
S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (2 up RBD and 1 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx8.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG HHblits 0.62
7dx0.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2
 0.67 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dwx.1.I
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG HHblits 0.62
7dwz.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.69 99.84 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.69 99.84 1.00 1-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG HHblits 0.62
8cya.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
 0.64 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUC HHblits 0.62
8cya.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
 0.64 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUC HHblits 0.62
8cya.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
 0.64 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUC HHblits 0.62
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.68 99.84 1.00 1-1273 EM 0.00 homo-trimer HHblits 0.62
7l7k.1.C
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.68 99.84 1.00 1-1273 EM 0.00 homo-trimer HHblits 0.62
8cxq.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cy7.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG HHblits 0.62
8cyc.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.65 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cxn.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.63 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 28 x NAG HHblits 0.62
8cy6.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.68 99.84 1.00 1-1273 EM 0.00 homo-trimer HHblits 0.62
8cyb.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG HHblits 0.62
8cyb.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG HHblits 0.62
8cy9.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.66 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cy6.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cy7.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG HHblits 0.62
8cxq.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cy6.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cyc.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.64 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cxn.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.63 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 28 x NAG HHblits 0.62
8cyb.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG HHblits 0.62
8cxq.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.67 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cyj.1.E
Spike glycoprotein
RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25
 0.02 99.84 1.00 1-1273 EM 0.00 hetero-1-1-1-1-1-mer HHblits 0.62
8cy7.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG HHblits 0.62
8cy9.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.66 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cyc.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.66 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
8cxn.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.65 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer 28 x NAG HHblits 0.62
8cy9.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.64 99.84 1.00 1-1273 EM 0.00 hetero-3-3-mer HHblits 0.62
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx2.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx2.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7dx2.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 1.00 1-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG HHblits 0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.69 99.61 1.00 1-1273 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG HHblits 0.62
7jji.1.B
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.69 99.61 1.00 1-1273 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG HHblits 0.62
7jji.1.C
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.69 99.61 1.00 1-1273 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG HHblits 0.62
7jjj.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7jjj.1.B
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7jjj.1.C
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7jjj.1.D
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7jjj.1.E
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7jjj.1.F
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers
 0.67 99.61 1.00 1-1273 EM 0.00 homo-hexamer 16 x NAG, 76 x NAG-NAG, 2 x NAG-NAG-FUC, 2 x NAG-NAG-BMA-FUC HHblits 0.62
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
 0.72 99.53 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x EIC, 24 x NAG-NAG HHblits 0.62
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 99.53 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.62
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 99.53 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.62
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.67 99.53 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG HHblits 0.62
7sbp.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7sbp.1.B
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7sbp.1.C
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7sbq.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbq.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.73 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbq.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbr.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbr.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.73 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbr.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 1.00 1-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN HHblits 0.62
7sbs.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.06 1.00 1-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbs.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.06 1.00 1-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbs.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.06 1.00 1-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7sbt.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.06 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
7sbt.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.06 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
7sbt.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.06 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN HHblits 0.61
7sbk.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbk.1.B
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbk.1.C
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbl.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 99.29 1.00 1-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbl.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.72 99.29 1.00 1-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbl.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbo.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbo.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7sbo.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC HHblits 0.62
7n1t.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7n1t.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7n1t.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 99.29 1.00 1-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.62
7n1q.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.74 99.29 1.00 1-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7n1q.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.29 1.00 1-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7n1q.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.29 1.00 1-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.62
7wg9.1.A
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.68 99.21 1.00 1-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG HHblits 0.62
7wg9.1.B
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.69 99.21 1.00 1-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG HHblits 0.62
7wg9.1.C
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.68 99.21 1.00 1-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG HHblits 0.62
7wwl.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.68 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwl.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.69 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwl.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.68 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7wwm.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.82 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG HHblits 0.61
7n1u.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 98.98 1.00 1-1273 EM 0.00 homo-trimer 24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1u.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 98.98 1.00 1-1273 EM 0.00 homo-trimer 24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1u.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 98.98 1.00 1-1273 EM 0.00 homo-trimer 24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1v.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 98.98 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1v.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 98.98 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1v.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 98.98 1.00 1-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1w.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1w.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1w.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1x.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1x.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1x.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 98.98 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1y.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.69 98.98 1.00 1-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1y.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 98.98 1.00 1-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
7n1y.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.69 98.98 1.00 1-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN HHblits 0.61
8dt3.1.A
Spike glycoprotein
Cryo-EM structure of spike binding to Fab of neutralizing antibody (locally refined)
 0.06 100.00 0.99 12-1273 EM 0.00 hetero-1-1-1-mer BLAST 0.62
6xra.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.10 100.00 0.99 12-1273 EM 0.00 homo-trimer 9 x NAG, 6 x NAG-NAG, 6 x NAG-NAG-MAN-MAN, 3 x NAG-NAG-MAN BLAST 0.62
6xr8.1.A
Spike glycoprotein
Distinct conformational states of SARS-CoV-2 spike protein
 0.72 100.00 0.99 12-1273 EM 0.00 homo-trimer 21 x NAG, 21 x NAG-NAG-MAN, 9 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN-MAN BLAST 0.62
7cwn.1.A
Spike glycoprotein
P17-H014 Fab cocktail in complex with SARS-CoV-2 spike protein
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG BLAST 0.62
7cwm.1.B
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.62
7cwm.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.62
7cwm.1.A
Spike glycoprotein
Complex of SARS-CoV-2 spike protein and Fab P17 with one RBD in open state and two RBD in closed state
 0.68 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 16 x NAG, 14 x NAG-NAG BLAST 0.62
7cwu.1.G
Spike glycoprotein
SARS-CoV-2 spike proteins trimer in complex with P17 and FC05 Fabs cocktail
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-3-3-mer 16 x NAG, 15 x NAG-NAG BLAST 0.62
7cwl.1.C
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG BLAST 0.62
7cwl.1.A
Spike glycoprotein
SARS-CoV-2 spike protein and P17 fab complex with one RBD in close state
 0.69 100.00 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG BLAST 0.62
7n64.1.B
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.04 100.00 0.99 12-1273 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.62
7n62.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with C12C9 Fab (NTD local reconstruction)
 0.07 100.00 0.99 12-1273 EM 0.00 hetero-1-1-1-mer 5 x NAG BLAST 0.62
7n64.1.A
Spike glycoprotein
SARS-CoV-2 Spike (2P) in complex with G32R7 Fab (RBD and NTD local reconstruction)
 0.07 100.00 0.99 12-1273 EM 0.00 hetero-2-1-1-mer 2 x NAG, 1 x NAG-NAG, 1 x NAG-NAG-BMA BLAST 0.62
7fg3.1.A
Spike glycoprotein
Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map
 0.56 100.00 0.99 12-1273 EM 0.00 hetero-1-1-mer BLAST 0.62
7fg7.1.A
Spike glycoprotein
Cryo-EM structure of S protein trimer of SARS-CoV2
 0.60 100.00 0.99 12-1273 EM 0.00 monomer BLAST 0.62
7fg2.1.A
Spike glycoprotein
Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map
 0.60 100.00 0.99 12-1273 EM 0.00 hetero-1-1-mer BLAST 0.62
7f3q.1.A
Spike glycoprotein
SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab
 0.03 100.00 0.99 12-1273 EM 0.00 hetero-1-1-1-1-1-mer 1 x NAG, 1 x MES BLAST 0.62
7krq.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 0.99 12-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC BLAST 0.62
7krr.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.72 99.92 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7krr.1.C
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7krs.1.A
Spike glycoprotein
Structural impact on SARS-CoV-2 spike protein by D614G substitution
 0.71 99.92 0.99 12-1273 EM 3.20 homo-trimer 21 x NAG, 30 x NAG-NAG, 3 x NAG-NAG-FUC, 3 x NAG-NAG-MAN BLAST 0.62
7upy.1.C
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.72 99.92 0.99 12-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC BLAST 0.62
7upy.1.A
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.72 99.92 0.99 12-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC BLAST 0.62
7upy.1.B
Spike glycoprotein
One RBD-up state of SARS-CoV-2 D614G spike in complex with the SP1-77 neutralizing antibody Fab fragment
 0.73 99.92 0.99 12-1273 EM 3.10 hetero-3-3-3-mer 23 x NAG, 16 x NAG-NAG, 12 x NAG-NAG-MAN, 6 x NAG-NAG-FUC BLAST 0.62
8gjm.1.A
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.72 99.92 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN BLAST 0.62
8gjm.1.C
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.70 99.92 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN BLAST 0.62
8gjm.1.B
Spike glycoprotein
17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer
 0.72 99.92 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 25 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 5 x NAG-NAG-MAN BLAST 0.62
6zwv.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs
 0.67 99.92 0.99 12-1273 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG BLAST 0.62
7d0d.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7ct5.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7c2l.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.66 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7c2l.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.70 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7c2l.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with 4A8
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 6 x NAG-NAG-NAG, 23 x NAG-NAG BLAST 0.62
7ct5.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7czt.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G9
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d0b.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d00.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7d0d.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7czv.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B6_3B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7ct5.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with T-ACE2
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 35 x NAG-NAG BLAST 0.62
7czw.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czs.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B8_3B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7czp.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG BLAST 0.62
7czw.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-2G7
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7d0b.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_1B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czp.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P2B-1A1
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 23 x NAG-NAG BLAST 0.62
7d0c.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3A1
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7d03.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-2G7
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 28 x NAG, 20 x NAG-NAG BLAST 0.62
7czx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7d0d.1.G
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7d00.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with FabP5A-1B8
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 27 x NAG, 21 x NAG-NAG BLAST 0.62
7czx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex bound with P5A-1B9
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 29 x NAG, 19 x NAG-NAG BLAST 0.62
7dwx.1.H
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dwy.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in the locked conformation
 0.72 99.84 0.99 12-1273 EM 0.00 homo-trimer 47 x NAG, 3 x EIC, 11 x NAG-NAG BLAST 0.62
7dwz.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in the active conformation
 0.69 99.84 0.99 12-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx7.1.A
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG BLAST 0.62
7dwx.1.E
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dx7.1.C
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound)
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-1-mer 27 x NAG, 27 x NAG-NAG BLAST 0.62
7dwx.1.F
Spike glycoprotein
Conformation 1 of S-ACE2-B0AT1 ternary complex
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-2-2-6-mer 62 x NAG, 2 x LEU, 2 x ZN, 58 x NAG-NAG BLAST 0.62
7dx9.1.B
Spike glycoprotein
Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 3 (3 up RBD and 2 PD bound)
 0.69 99.84 0.99 12-1273 EM 0.00 hetero-3-2-mer 28 x NAG, 32 x NAG-NAG BLAST 0.62
8cya.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-67
 0.64 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 32 x NAG, 14 x NAG-NAG-BMA, 4 x NAG-NAG, 2 x NAG-NAG-FUC BLAST 0.62
7l7k.1.A
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.68 99.84 0.99 12-1273 EM 0.00 homo-trimer BLAST 0.62
8cxq.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cy7.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG BLAST 0.62
8cyc.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.65 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cxn.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.63 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 28 x NAG BLAST 0.62
8cy6.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
7l7k.1.B
Spike glycoprotein
Cryo-EM structure of protein encoded by vaccine candidate BNT162b2
 0.68 99.84 0.99 12-1273 EM 0.00 homo-trimer BLAST 0.62
8cyb.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG BLAST 0.62
8cyb.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG BLAST 0.62
8cy9.1.B
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.66 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cy6.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cy7.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG BLAST 0.62
8cxq.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cy6.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
 0.68 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cyc.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.64 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cxn.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.63 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 28 x NAG BLAST 0.62
8cyb.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-1-mer 32 x NAG, 4 x NAG-NAG, 7 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-FUC-GAL-FUC-NAG-BMA, 7 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN, 1 x NAG-FUC-NAG BLAST 0.62
8cxq.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22
 0.67 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cyj.1.E
Spike glycoprotein
RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25
 0.02 99.84 0.99 12-1273 EM 0.00 hetero-1-1-1-1-1-mer BLAST 0.62
8cy7.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.61 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 31 x NAG, 12 x NAG-NAG BLAST 0.62
8cy9.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.66 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cyc.1.C
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
 0.66 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
8cxn.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
 0.65 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer 28 x NAG BLAST 0.62
8cy9.1.A
Spike glycoprotein
SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
 0.64 99.84 0.99 12-1273 EM 0.00 hetero-3-3-mer BLAST 0.62
7dx1.1.A
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.68 99.76 0.99 12-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx1.1.B
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 0.99 12-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7dx1.1.C
Spike glycoprotein
S protein of SARS-CoV-2 D614G mutant
 0.67 99.76 0.99 12-1273 EM 0.00 homo-trimer 26 x NAG, 22 x NAG-NAG BLAST 0.62
7jji.1.A
Spike glycoprotein
Structure of SARS-CoV-2 3Q-2P full-length prefusion spike trimer (C3 symmetry)
 0.69 99.60 0.99 12-1273 EM 0.00 homo-trimer 3 x NAG, 3 x VCG, 3 x EIC, 45 x NAG-NAG BLAST 0.62
7x08.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with 2G1
 0.72 99.52 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x EIC, 24 x NAG-NAG BLAST 0.62
7epx.1.B
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 99.52 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.62
7epx.1.A
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.69 99.52 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.62
7epx.1.C
Spike glycoprotein
S protein of SARS-CoV-2 in complex with GW01
 0.67 99.52 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 25 x NAG, 23 x NAG-NAG BLAST 0.62
7sbp.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 0.99 12-1273 EM 3.44 homo-trimer 21 x NAG, 6 x NAG-NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG-FUC BLAST 0.62
7sbq.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbq.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbq.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbr.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbr.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.72 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbr.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Kappa variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.50 homo-trimer 24 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 11 x NAG-NAG-MAN BLAST 0.62
7sbs.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.05 0.99 12-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7sbs.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.05 0.99 12-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7sbs.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.05 0.99 12-1273 EM 3.50 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7sbt.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.69 99.05 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN BLAST 0.62
7sbt.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.05 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN BLAST 0.62
7sbt.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Gamma variant spike protein
 0.70 99.05 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-FUC, 9 x NAG-NAG-MAN BLAST 0.62
7sbk.1.A
Spike glycoprotein
Closed state of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.44 homo-trimer 21 x NAG, 27 x NAG-NAG-MAN, 3 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbl.1.A
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 99.37 0.99 12-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbl.1.B
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.72 99.37 0.99 12-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbl.1.C
Spike glycoprotein
One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.44 homo-trimer 25 x NAG, 10 x NAG-NAG-MAN, 16 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbo.1.A
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.70 99.37 0.99 12-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbo.1.B
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7sbo.1.C
Spike glycoprotein
One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein
 0.71 99.37 0.99 12-1273 EM 3.44 homo-trimer 24 x NAG, 10 x NAG-NAG-MAN, 17 x NAG-NAG, 3 x NAG-NAG-FUC BLAST 0.62
7n1t.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 99.36 0.99 12-1273 EM 3.44 homo-trimer 24 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC BLAST 0.62
7n1q.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.74 99.36 0.99 12-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1q.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.36 0.99 12-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1q.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.36 0.99 12-1273 EM 3.44 homo-trimer 29 x NAG, 19 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7wg9.1.A
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.68 99.29 0.99 12-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG BLAST 0.62
7wg9.1.B
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.69 99.29 0.99 12-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG BLAST 0.62
7wg9.1.C
Spike glycoprotein
Delta Spike Trimer(1 RBD Up)
 0.69 99.29 0.99 12-1273 EM 0.00 homo-trimer 35 x NAG, 13 x NAG-NAG BLAST 0.62
7n1u.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 99.44 0.99 12-1273 EM 0.00 homo-trimer 24 x NAG, 24 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1v.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.44 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1v.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 99.44 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1v.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.44 0.99 12-1273 EM 3.50 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1w.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1w.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.73 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1w.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.72 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1x.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1x.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.71 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1x.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 99.44 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 20 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1y.1.A
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.69 99.44 0.99 12-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1y.1.B
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.70 99.44 0.99 12-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7n1y.1.C
Spike glycoprotein
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
 0.69 99.44 0.99 12-1273 EM 0.00 homo-trimer 32 x NAG, 16 x NAG-NAG, 3 x NAG-NAG-FUC, 6 x NAG-NAG-MAN BLAST 0.62
7wwl.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.68 98.89 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7wwl.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWD12
 0.69 98.89 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7wwm.1.A
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.89 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7wwm.1.B
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.89 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7wwm.1.C
Spike glycoprotein
S protein of Delta variant in complex with ZWC6
 0.68 98.89 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 25 x NAG, 23 x NAG-NAG BLAST 0.61
7x6a.1.A
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
 0.65 97.09 1.00 1-1273 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7x6a.1.B
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
 0.65 97.09 1.00 1-1273 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7xiw.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
 0.65 97.09 1.00 1-1273 EM 3.62 homo-trimer 29 x NAG, 13 x NAG-NAG HHblits 0.61
7x6a.1.C
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
 0.63 97.09 1.00 1-1273 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7xiw.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
 0.63 97.09 1.00 1-1273 EM 3.62 homo-trimer 29 x NAG, 13 x NAG-NAG HHblits 0.61
7xiw.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
 0.65 97.09 1.00 1-1273 EM 3.62 homo-trimer 29 x NAG, 13 x NAG-NAG HHblits 0.61
7xix.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
 0.67 97.09 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7xix.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
 0.67 97.09 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7xix.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
 0.67 97.09 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7xnr.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
 0.64 97.01 1.00 1-1273 EM 0.00 homo-trimer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7xnr.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
 0.64 97.01 1.00 1-1273 EM 0.00 homo-trimer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7xnr.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
 0.65 97.01 1.00 1-1273 EM 0.00 homo-trimer 27 x NAG, 15 x NAG-NAG HHblits 0.61
7xo7.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.67 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.61
7xoa.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.66 96.93 1.00 1-1273 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN HHblits 0.61
7xoa.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.67 96.93 1.00 1-1273 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN HHblits 0.61
7xob.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
 0.67 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 37 x NAG, 2 x ZN HHblits 0.61
7xo7.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.68 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.61
7xo8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.68 96.93 1.00 1-1273 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN HHblits 0.61
7xo9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with human ACE2
 0.02 96.93 1.00 1-1273 EM 0.00 hetero-1-1-mer 1 x ZN, 3 x NAG HHblits 0.61
7xo7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.67 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN HHblits 0.61
7xo8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.68 96.93 1.00 1-1273 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN HHblits 0.61
7xo8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.68 96.93 1.00 1-1273 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN HHblits 0.61
7xoa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.69 96.93 1.00 1-1273 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN HHblits 0.61
7xob.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
 0.69 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 37 x NAG, 2 x ZN HHblits 0.61
7xob.1.D
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two mouse ACE2 Bound
 0.69 96.93 1.00 1-1273 EM 0.00 hetero-3-2-mer 37 x NAG, 2 x ZN HHblits 0.61
7xoc.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant RBD complexed with mouse ACE2
 0.02 96.93 1.00 1-1273 EM 0.00 hetero-1-1-mer 1 x ZN, 2 x NAG, 1 x NAG-NAG HHblits 0.61
7xod.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.68 96.93 1.00 1-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG HHblits 0.61
7xod.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.67 96.93 1.00 1-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG HHblits 0.61
7xod.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.70 96.93 1.00 1-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG HHblits 0.61
7xns.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.64 96.85 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7xns.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.64 96.85 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7xns.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.64 96.85 1.00 1-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7we7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.69 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we7.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.69 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we7.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.67 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.66 96.85 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.64 96.85 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.65 96.85 1.00 1-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.61 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.63 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7we9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.61 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wea.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.67 96.85 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wea.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.65 96.85 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wea.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.68 96.85 1.00 1-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7web.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.65 96.85 1.00 1-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7web.1.F
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.67 96.85 1.00 1-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7web.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.68 96.85 1.00 1-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wec.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.69 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wec.1.H
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.67 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wec.1.I
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.68 96.85 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wee.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265
 0.05 96.85 1.00 1-1273 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7tnw.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7tnw.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7tnw.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC HHblits 0.61
7to4.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN HHblits 0.61
7to4.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN HHblits 0.61
7to4.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 96.77 1.00 1-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN HHblits 0.61
7xnq.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.63 96.69 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 18 x NAG-NAG HHblits 0.61
7xnq.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.63 96.69 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 18 x NAG-NAG HHblits 0.61
7xnq.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.63 96.69 1.00 1-1273 EM 0.00 homo-trimer 33 x NAG, 18 x NAG-NAG HHblits 0.61
7wgb.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.67 96.69 1.00 1-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wgb.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.68 96.69 1.00 1-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wgb.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.66 96.69 1.00 1-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.61
7wg7.1.A
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.62 96.45 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.60
7wg7.1.B
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.64 96.45 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.60
7wg7.1.C
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.61 96.45 1.00 1-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA HHblits 0.60
7wgc.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2.
 0.03 96.45 1.00 1-1273 EM 0.00 hetero-1-1-mer 5 x NAG HHblits 0.60
7xiy.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
 0.66 96.61 1.00 1-1273 EM 0.00 homo-trimer 23 x NAG, 12 x NAG-NAG HHblits 0.60
7xiy.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
 0.66 96.61 1.00 1-1273 EM 0.00 homo-trimer 23 x NAG, 12 x NAG-NAG HHblits 0.60
7xiy.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
 0.66 96.61 1.00 1-1273 EM 0.00 homo-trimer 23 x NAG, 12 x NAG-NAG HHblits 0.60
7yqw.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.67 96.29 1.00 1-1273 EM 3.51 homo-trimer 33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAG HHblits 0.60
7yqw.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.67 96.29 1.00 1-1273 EM 3.51 homo-trimer 33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAG HHblits 0.60
7yqw.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.67 96.29 1.00 1-1273 EM 3.51 homo-trimer 33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAG HHblits 0.60
7yqt.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.64 96.29 1.00 1-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG HHblits 0.60
7yqt.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.65 96.29 1.00 1-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG HHblits 0.60
7yqv.1.A
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.62 96.29 1.00 1-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG HHblits 0.60
7yqv.1.B
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.64 96.29 1.00 1-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG HHblits 0.60
7yqv.1.C
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.64 96.29 1.00 1-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG HHblits 0.60
7yqt.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.64 96.29 1.00 1-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG HHblits 0.60
7yqx.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.63 96.29 1.00 1-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yqx.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.63 96.29 1.00 1-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yqx.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.64 96.29 1.00 1-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yqy.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.64 96.29 1.00 1-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC HHblits 0.60
7yqy.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.62 96.29 1.00 1-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC HHblits 0.60
7yqy.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.64 96.29 1.00 1-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC HHblits 0.60
7yqz.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.65 96.29 1.00 1-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yqz.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.65 96.29 1.00 1-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yqz.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.66 96.29 1.00 1-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC HHblits 0.60
7yr1.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
 0.66 96.29 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMA HHblits 0.60
7yr1.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
 0.66 96.29 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMA HHblits 0.60
7yr1.1.G
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
 0.66 96.29 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMA HHblits 0.60
7yr2.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.64 96.29 1.00 1-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG HHblits 0.60
7yr2.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.65 96.29 1.00 1-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG HHblits 0.60
7yr2.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.67 96.29 1.00 1-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG HHblits 0.60
7yr3.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.65 96.29 1.00 1-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.60
7yr3.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.66 96.29 1.00 1-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.60
7yr3.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.66 96.29 1.00 1-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG HHblits 0.60
7yqu.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.68 96.29 1.00 1-1273 EM 3.19 homo-trimer 36 x NAG, 6 x NAG-NAG HHblits 0.60
7yqu.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.68 96.29 1.00 1-1273 EM 3.19 homo-trimer 36 x NAG, 6 x NAG-NAG HHblits 0.60
7yqu.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.68 96.29 1.00 1-1273 EM 3.19 homo-trimer 36 x NAG, 6 x NAG-NAG HHblits 0.60
7wti.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.65 96.21 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG HHblits 0.60
7wti.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.63 96.21 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG HHblits 0.60
7wti.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.62 96.21 1.00 1-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG HHblits 0.60
7we7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.69 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we7.1.D
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.69 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we7.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv282
 0.67 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we8.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.66 97.69 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.64 97.69 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we8.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv265
 0.65 97.69 0.99 12-1273 EM 0.00 hetero-3-1-1-mer 26 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we9.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.61 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we9.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.63 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7we9.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with Fab XGv289
 0.61 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wea.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.67 97.69 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wea.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.65 97.69 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wea.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein in complex with two XGv347 binding to one close state RBD and one open state RBD
 0.68 97.69 0.99 12-1273 EM 0.00 hetero-3-2-2-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7web.1.E
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.65 97.69 0.99 12-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7web.1.F
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.67 97.69 0.99 12-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7web.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with two XGv347 binding to two open state RBDs
 0.68 97.69 0.99 12-1273 EM 0.00 hetero-2-2-3-mer 29 x NAG, 15 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wec.1.G
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.69 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wec.1.H
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.67 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wec.1.I
Spike glycoprotein
SARS-CoV-2 Omicron variant spike protein with three XGv347 Fabs binding to three closed state RBDs
 0.67 97.69 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 31 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wee.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike RBD in complex with Fab XGv265
 0.04 97.69 0.99 12-1273 EM 0.00 hetero-1-1-1-mer BLAST 0.61
7x6a.1.A
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
 0.65 97.14 0.99 12-1273 EM 0.00 hetero-3-3-3-mer BLAST 0.61
7x6a.1.C
Spike glycoprotein
SARS-CoV-2 BA.2 variant spike protein in complex with Fab BD55-5840
 0.63 97.14 0.99 12-1273 EM 0.00 hetero-3-3-3-mer BLAST 0.61
7xiw.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 1)
 0.65 97.14 0.99 12-1273 EM 3.62 homo-trimer 29 x NAG, 13 x NAG-NAG BLAST 0.61
7xix.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 variant spike (state 2)
 0.66 97.14 0.99 12-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG BLAST 0.61
7tnw.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 97.53 0.99 12-1273 EM 0.00 homo-trimer 21 x NAG, 9 x NAG-NAG, 21 x NAG-NAG-MAN, 3 x NAG-NAG-FUC BLAST 0.61
7to4.1.A
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 97.53 0.99 12-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN BLAST 0.61
7to4.1.B
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 97.53 0.99 12-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN BLAST 0.61
7to4.1.C
Spike glycoprotein
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
 0.71 97.53 0.99 12-1273 EM 0.00 homo-trimer 25 x NAG, 11 x NAG-NAG, 3 x NAG-NAG-FUC, 15 x NAG-NAG-MAN BLAST 0.61
7xnr.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2.13 variant spike
 0.64 97.06 0.99 12-1273 EM 0.00 homo-trimer 27 x NAG, 15 x NAG-NAG BLAST 0.61
7xo7.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.67 97.06 0.99 12-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST 0.61
7xo7.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.67 97.06 0.99 12-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST 0.61
7xo7.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with two human ACE2 Bound
 0.67 97.06 0.99 12-1273 EM 0.00 hetero-3-2-mer 39 x NAG, 2 x ZN BLAST 0.61
7xo8.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three human ACE2 Bound
 0.68 97.06 0.99 12-1273 EM 0.00 hetero-3-3-mer 39 x NAG, 3 x ZN BLAST 0.61
7xoa.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with one mouse ACE2 Bound
 0.68 97.06 0.99 12-1273 EM 0.00 hetero-3-1-mer 34 x NAG, 1 x ZN BLAST 0.61
7xod.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.67 97.06 0.99 12-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG BLAST 0.61
7xod.1.B
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.67 97.06 0.99 12-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG BLAST 0.61
7xod.1.C
Spike glycoprotein
SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound
 0.70 97.06 0.99 12-1273 EM 0.00 hetero-3-3-3-3-mer 35 x NAG, 2 x NAG-NAG BLAST 0.61
7wgb.1.A
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.67 97.45 0.99 12-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wgb.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.68 97.45 0.99 12-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wgb.1.C
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2
 0.66 97.45 0.99 12-1273 EM 0.00 hetero-3-2-mer 33 x NAG, 16 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7xns.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.64 96.98 0.99 12-1273 EM 0.00 homo-trimer 30 x NAG, 18 x NAG-NAG BLAST 0.61
7wg7.1.A
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.62 97.21 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wg7.1.B
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.64 97.21 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wg7.1.C
Spike glycoprotein
Acidic Omicron Spike Trimer
 0.61 97.21 0.99 12-1273 EM 0.00 homo-trimer 28 x NAG, 14 x NAG-NAG, 5 x NAG-NAG-BMA BLAST 0.61
7wgc.1.B
Spike glycoprotein
Neutral Omicron Spike Trimer in complex with ACE2.
 0.02 97.21 0.99 12-1273 EM 0.00 hetero-1-1-mer 5 x NAG BLAST 0.61
7xiy.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.3 variant spike
 0.65 97.21 0.99 12-1273 EM 0.00 homo-trimer 23 x NAG, 12 x NAG-NAG BLAST 0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.63 99.52 0.97 14-1254 EM 0.00 homo-trimer HHblits 0.62
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.61 99.52 0.97 14-1254 EM 0.00 homo-trimer HHblits 0.62
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.63 99.52 0.97 14-1254 EM 0.00 homo-trimer HHblits 0.62
7xnq.1.A
Spike glycoprotein
SARS-CoV-2 Omicron BA.4 variant spike
 0.63 96.98 0.99 12-1273 EM 0.00 homo-trimer 33 x NAG, 18 x NAG-NAG BLAST 0.61
7yqw.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.66 96.66 0.99 12-1273 EM 3.51 homo-trimer 33 x NAG, 6 x NAG-NAG-BMA, 9 x NAG-NAG BLAST 0.61
7yqt.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.63 96.66 0.99 12-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG BLAST 0.61
7yqt.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.64 96.66 0.99 12-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG BLAST 0.61
7yqv.1.A
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.61 96.66 0.99 12-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG BLAST 0.61
7yqv.1.B
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.63 96.66 0.99 12-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG BLAST 0.61
7yqv.1.C
Spike glycoprotein
pH 5.5 SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.63 96.66 0.99 12-1273 EM 0.00 homo-trimer 44 x NAG, 9 x NAG-NAG BLAST 0.61
7yqt.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (1 RBD Up)
 0.63 96.66 0.99 12-1273 EM 0.00 homo-trimer 45 x NAG, 9 x NAG-NAG BLAST 0.61
7yqx.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.62 96.66 0.99 12-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yqx.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.62 96.66 0.99 12-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yqx.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state1)
 0.63 96.66 0.99 12-1273 EM 3.72 hetero-3-2-2-mer 45 x NAG, 9 x NAG-NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yqy.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.63 96.66 0.99 12-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC BLAST 0.61
7yqy.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.61 96.66 0.99 12-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC BLAST 0.61
7yqy.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state2)
 0.62 96.66 0.99 12-1273 EM 3.74 hetero-3-3-3-mer 44 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA-FUC BLAST 0.61
7yqz.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.65 96.66 0.99 12-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yqz.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.65 96.66 0.99 12-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yqz.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with S309 (state3)
 0.65 96.66 0.99 12-1273 EM 3.84 hetero-3-2-2-mer 45 x NAG, 2 x NAG-NAG-BMA-FUC BLAST 0.61
7yr1.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with XG2v024
 0.66 96.66 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 24 x NAG, 15 x NAG-NAG, 9 x NAG-NAG-BMA BLAST 0.61
7yr2.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.63 96.66 0.99 12-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST 0.61
7yr2.1.C
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.64 96.66 0.99 12-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST 0.61
7yr2.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state1)
 0.66 96.66 0.99 12-1273 EM 3.30 hetero-1-3-mer 1 x ZN, 48 x NAG, 9 x NAG-NAG BLAST 0.61
7yr3.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.64 96.66 0.99 12-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yr3.1.B
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.65 96.66 0.99 12-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yr3.1.D
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer in complex with ACE2(state2)
 0.65 96.66 0.99 12-1273 EM 3.52 hetero-3-2-mer 45 x NAG, 2 x ZN, 9 x NAG-NAG BLAST 0.61
7yqu.1.A
Spike glycoprotein
SARS-CoV-2 BA.2.75 S Trimer (3 RBD Down)
 0.68 96.66 0.99 12-1273 EM 3.19 homo-trimer 36 x NAG, 6 x NAG-NAG BLAST 0.61
7wti.1.A
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.65 96.97 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG BLAST 0.61
7wti.1.B
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.63 96.97 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG BLAST 0.61
7wti.1.C
Spike glycoprotein
SARS-CoV-2 Omicron variant spike in complex with Fab XGv264
 0.63 96.97 0.99 12-1273 EM 0.00 hetero-3-3-3-mer 36 x NAG BLAST 0.61
7dzw.1.A
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.62 99.51 0.96 14-1232 EM 0.00 homo-trimer BLAST 0.62
7dzw.1.B
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.60 99.51 0.96 14-1232 EM 0.00 homo-trimer BLAST 0.62
7dzw.1.C
Spike glycoprotein
Apo spike protein from SARS-CoV2
 0.62 99.51 0.96 14-1232 EM 0.00 homo-trimer BLAST 0.62
7qus.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
 0.69 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7qur.1.A
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
 0.68 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7qus.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
 0.69 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7qur.1.B
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
 0.68 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7qus.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike, C3 symmetry
 0.69 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
7qur.1.C
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike with ethylbenzamide-tri-iodo Siallyllactose, C3 symmetry
 0.68 99.26 0.96 1-1221 EM 0.00 homo-trimer 36 x NAG, 3 x GE9, 3 x SIA, 3 x EIC, 9 x NAG-NAG, 3 x NAG-FUC-NAG-FUC HHblits 0.61
6zb4.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
 0.72 99.92 0.95 1-1213 EM 0.00 homo-trimer 25 x NAG, 3 x EIC, 1 x NAG-NAG HHblits 0.62
6zb4.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
 0.72 99.92 0.95 1-1213 EM 0.00 homo-trimer 25 x NAG, 3 x EIC, 1 x NAG-NAG HHblits 0.62
6zb4.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C1 symmetry
 0.73 99.92 0.95 1-1213 EM 0.00 homo-trimer 25 x NAG, 3 x EIC, 1 x NAG-NAG HHblits 0.62
6zb5.1.A
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
 0.72 99.92 0.95 1-1213 EM 0.00 homo-trimer 20 x NAG, 3 x EIC, 3 x NAG-NAG HHblits 0.62
6zb5.1.B
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
 0.72 99.92 0.95 1-1213 EM 0.00 homo-trimer 20 x NAG, 3 x EIC, 3 x NAG-NAG HHblits 0.62
6zb5.1.C
Spike glycoprotein
SARS CoV-2 Spike protein, Closed conformation, C3 symmetry
 0.72 99.92 0.95 1-1213 EM 0.00 homo-trimer 20 x NAG, 3 x EIC, 3 x NAG-NAG HHblits 0.62
7k8s.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.68 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.62
7k8s.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.67 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.62
7k8s.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1)
 0.68 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 15 x NAG-NAG HHblits 0.62
7k8t.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.68 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.62
7k8t.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.68 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.62
7k8t.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2)
 0.68 99.84 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 30 x NAG, 15 x NAG-NAG HHblits 0.62
7k8x.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.67 99.84 0.95 1-1213 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.62
7k8x.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.68 99.84 0.95 1-1213 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.62
7k8x.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1)
 0.67 99.84 0.95 1-1213 EM 3.90 hetero-3-2-2-mer 28 x NAG HHblits 0.62
7k8y.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.84 0.95 1-1213 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.62
7k8y.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.84 0.95 1-1213 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.62
7k8y.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2)
 0.67 99.84 0.95 1-1213 EM 4.40 hetero-3-1-1-mer 23 x NAG HHblits 0.62
7m6i.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.65 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.62
7m6h.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.59 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.62
7m6h.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.59 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.62
7m6i.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.63 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.62
7m6i.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG1-24
 0.64 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 26 x NAG, 3 x NAG-NAG, 1 x NAG-NAG-BMA-MAN, 1 x NAG-NAG-BMA HHblits 0.62
7m6h.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, BG7-20
 0.57 99.84 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 28 x NAG HHblits 0.62
8d48.1.A
Spike glycoprotein
sd1.040 Fab in complex with SARS-CoV-2 Spike 2P glycoprotein
 0.08 99.84 0.95 1-1213 EM 0.00 hetero-1-1-1-mer 1 x NAG-NAG HHblits 0.62
6xcm.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.69 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.62
6xcn.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
 0.69 99.75 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUC HHblits 0.62
6xcn.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
 0.69 99.75 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUC HHblits 0.62
6xcn.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 2)
 0.69 99.75 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 24 x NAG, 9 x NAG-NAG, 3 x NAG-NAG-BMA, 3 x NAG-NAG-FUC HHblits 0.62
6xcm.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.62
6xcm.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the C105 neutralizing antibody Fab fragment (state 1)
 0.67 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 30 x NAG, 9 x NAG-NAG, 1 x NAG-FUC, 2 x NAG-NAG-FUC, 1 x NAG-NAG-BMA HHblits 0.62
7k8z.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.69 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.62
7k8v.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.64 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.62
7k8w.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.67 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.62
7k8w.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.62
7k8v.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.62 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.62
7k8u.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.66 99.75 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.62
7k8u.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.62
7k8v.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110
 0.64 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 21 x NAG, 10 x NAG-NAG HHblits 0.62
7k8w.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 34 x NAG, 13 x NAG-NAG HHblits 0.62
7k8z.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.62
7k8z.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 33 x NAG, 13 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x NAG-NAG-BMA-FUC HHblits 0.62
7k8u.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104
 0.68 99.75 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 2 x NAG, 1 x NAG-NAG HHblits 0.62
7e7d.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
 0.73 99.75 0.95 1-1214 EM 3.20 homo-trimer 19 x NAG, 3 x ELA, 32 x NAG-NAG HHblits 0.62
7e7d.1.B
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
 0.73 99.75 0.95 1-1214 EM 3.20 homo-trimer 19 x NAG, 3 x ELA, 32 x NAG-NAG HHblits 0.62
7e7d.1.C
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate
 0.73 99.75 0.95 1-1214 EM 3.20 homo-trimer 19 x NAG, 3 x ELA, 32 x NAG-NAG HHblits 0.62
7e7b.1.A
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
 0.71 99.67 0.95 1-1214 EM 0.00 homo-trimer 15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAG HHblits 0.61
7e7b.1.B
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
 0.71 99.67 0.95 1-1214 EM 0.00 homo-trimer 15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAG HHblits 0.61
7e7b.1.C
Spike glycoprotein,Collagen alpha-1(I) chain
Cryo-EM structure of the SARS-CoV-2 furin site mutant S-Trimer from a subunit vaccine candidate
 0.71 99.67 0.95 1-1214 EM 0.00 homo-trimer 15 x NAG, 3 x ELA, 3 x VCG, 39 x NAG-NAG HHblits 0.61
8h3e.1.A
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
 0.63 99.34 0.95 1-1214 EM 0.00 homo-trimer 3 x Q83, 15 x NAG HHblits 0.61
8h3e.1.B
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
 0.63 99.34 0.95 1-1214 EM 0.00 homo-trimer 3 x Q83, 15 x NAG HHblits 0.61
8h3e.1.C
Spike glycoprotein,Fibritin
Complex structure of a small molecule (SPC-14) bound SARS-CoV-2 spike protein, closed state
 0.63 99.34 0.95 1-1214 EM 0.00 homo-trimer 3 x Q83, 15 x NAG HHblits 0.61
8h3d.1.B
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
 0.61 99.34 0.95 1-1214 EM 0.00 homo-trimer 13 x NAG HHblits 0.61
8h3d.1.C
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
 0.60 99.34 0.95 1-1214 EM 0.00 homo-trimer 13 x NAG HHblits 0.61
8h3d.1.A
Spike glycoprotein,Fibritin
Structure of apo SARS-CoV-2 spike protein with one RBD up
 0.63 99.34 0.95 1-1214 EM 0.00 homo-trimer 13 x NAG HHblits 0.61
7k9j.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
 0.67 99.50 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
7k9j.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
 0.67 99.50 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
7k9j.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation)
 0.67 99.50 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 3 x NAG, 12 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-NAG-BMA-FUC, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
7k9h.1.B
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.68 99.50 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
7k9h.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.67 99.50 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
7k9h.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation)
 0.67 99.50 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 3 x NAG, 14 x NAG-NAG-BMA, 21 x NAG-NAG, 3 x NAG-FUC, 3 x NAG-NAG-BMA-MAN HHblits 0.62
8gb0.1.A
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
 0.69 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.62
8gb0.1.B
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
 0.68 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.62
8gb0.1.C
Spike glycoprotein
SARS-CoV-2 Spike H655Y variant, One RBD Open
 0.68 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.62
6xs6.1.A
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
 0.49 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.61
6xs6.1.B
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
 0.49 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.61
6xs6.1.C
Spike glycoprotein
SARS-CoV-2 Spike D614G variant, minus RBD
 0.49 99.42 0.95 1-1213 EM 0.00 homo-trimer HHblits 0.61
7kdi.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.69 99.92 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdi.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.69 99.92 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdi.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.69 99.92 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdj.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.69 99.83 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7kdj.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.66 99.83 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7kdj.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G)
 0.68 99.83 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7z85.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z6v.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 28 x NAG, 19 x NAG-NAG HHblits 0.61
7z7x.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z86.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z9q.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
 0.69 99.26 0.95 1-1212 EM 3.60 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z9r.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z9q.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
 0.69 99.26 0.95 1-1212 EM 3.60 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z86.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z7x.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
 0.70 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z6v.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 28 x NAG, 19 x NAG-NAG HHblits 0.61
7z9r.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
 0.70 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z85.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
 0.70 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z9q.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
 0.70 99.26 0.95 1-1212 EM 3.60 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z86.1.A
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
 0.70 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z9r.1.C
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation
 0.68 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z85.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z7x.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
 0.69 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7z6v.1.B
Spike glycoprotein,Fibritin
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
 0.68 99.26 0.95 1-1212 EM 0.00 hetero-3-3-mer 28 x NAG, 19 x NAG-NAG HHblits 0.61
6z97.1.C
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.68 99.26 0.95 1-1212 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6zhd.1.B
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.69 99.26 0.95 1-1212 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
6z97.1.B
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.70 99.26 0.95 1-1212 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6z97.1.A
Spike glycoprotein,Fibritin
Structure of the prefusion SARS-CoV-2 spike glycoprotein
 0.69 99.26 0.95 1-1212 EM 0.00 homo-trimer 27 x NAG, 11 x NAG-NAG HHblits 0.61
6zhd.1.A
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.70 99.26 0.95 1-1212 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
6zhd.1.C
Spike glycoprotein,Fibritin
H11-H4 bound to Spike
 0.69 99.26 0.95 1-1212 EM 3.70 hetero-3-3-mer 26 x NAG, 20 x NAG-NAG HHblits 0.61
7a5r.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
 0.04 99.83 0.95 1-1208 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
7a5r.1.D
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement)
 0.04 99.83 0.95 1-1208 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
6zgi.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.83 0.95 1-1208 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG HHblits 0.62
6zgi.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.83 0.95 1-1208 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG HHblits 0.62
6zgi.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.83 0.95 1-1208 EM 0.00 homo-trimer 24 x NAG, 27 x NAG-NAG HHblits 0.62
6zgg.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.64 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
6zgg.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.64 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
6zgg.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect
 0.64 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
7a5s.1.E
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
 0.35 99.83 0.95 1-1208 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
7a5s.1.C
Spike glycoprotein
Complex of SARS-CoV-2 spike and CR3022 Fab (Homogeneous Refinement)
 0.35 99.83 0.95 1-1208 EM 0.00 hetero-2-2-2-mer 2 x NAG-NAG HHblits 0.62
7a93.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.63 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
7a95.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a96.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a98.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-3-mer HHblits 0.62
7a98.1.E
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.62 99.83 0.95 1-1208 EM 0.00 hetero-3-3-mer HHblits 0.62
7a98.1.F
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 3 ACE2 Bound
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-3-mer HHblits 0.62
7a94.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.68 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.68 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a94.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound
 0.68 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer 23 x NAG, 1 x ZN HHblits 0.62
7a97.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-2-mer HHblits 0.62
7a96.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a97.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-2-mer HHblits 0.62
7a93.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.63 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
7a97.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 ACE2 Bound
 0.62 99.83 0.95 1-1208 EM 0.00 hetero-3-2-mer HHblits 0.62
7a96.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Anticlockwise Direction
 0.62 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1.A
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a95.1.C
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound and 1 RBD Erect in Clockwise Direction
 0.63 99.83 0.95 1-1208 EM 0.00 hetero-3-1-mer HHblits 0.62
7a93.1.B
Spike glycoprotein
SARS-CoV-2 Spike Glycoprotein with 2 RBDs Erect
 0.62 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.B
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.65 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.A
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.54 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
6zgh.1.C
Spike glycoprotein
Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
 0.65 99.83 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.62
7a4n.1.A
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
 0.68 99.17 0.95 1-1212 EM 0.00 homo-trimer 15 x NAG, 3 x NAG-NAG HHblits 0.61
7a4n.1.B
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
 0.68 99.17 0.95 1-1212 EM 0.00 homo-trimer 15 x NAG, 3 x NAG-NAG HHblits 0.61
7a4n.1.C
Spike glycoprotein,Fibritin
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(S-closed trimer)
 0.68 99.17 0.95 1-1212 EM 0.00 homo-trimer 15 x NAG, 3 x NAG-NAG HHblits 0.61
7ad1.1.A
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.69 99.17 0.95 1-1212 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7ad1.1.B
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.68 99.17 0.95 1-1212 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7ad1.1.C
Spike glycoprotein,Envelope glycoprotein,Spike glycoprotein,Envelope glycoprotein,SARS-CoV-2 S protein
Cryo-EM structure of a prefusion stabilized SARS-CoV-2 Spike (D614N, R682S, R685G, A892P, A942P and V987P)(One up trimer)
 0.68 99.17 0.95 1-1212 EM 0.00 homo-trimer 10 x NAG, 10 x NAG-NAG HHblits 0.61
7q0a.1.A
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.69 99.34 0.95 1-1211 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.61
7q0a.1.B
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.70 99.34 0.95 1-1211 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.61
7q0a.1.C
Spike glycoprotein,Spike ectodomain,Spike protein S2'
SARS-CoV-2 Spike ectodomain with Fab FI3A
 0.68 99.34 0.95 1-1211 EM 0.00 hetero-3-1-1-mer 27 x NAG, 11 x NAG-NAG HHblits 0.61
7kdg.1.A
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.70 99.75 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdg.1.B
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.70 99.75 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdg.1.C
Spike glycoprotein
SARS-CoV-2 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.69 99.75 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdh.1.A
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.69 99.75 0.95 1-1208 EM 0.00 homo-trimer 49 x NAG HHblits 0.62
7kdh.1.B
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.65 99.75 0.95 1-1208 EM 0.00 homo-trimer 49 x NAG HHblits 0.62
7kdh.1.C
Spike glycoprotein
SARS-CoV-2 RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS)
 0.68 99.75 0.95 1-1208 EM 0.00 homo-trimer 49 x NAG HHblits 0.62
7kml.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
 0.63 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMA HHblits 0.61
7kml.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
 0.63 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMA HHblits 0.61
7kml.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, three RBDs bound
 0.63 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 18 x NAG, 21 x NAG-NAG, 6 x NAG-NAG-BMA HHblits 0.61
7kmk.1.B
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kmk.1.C
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kmk.1.A
Spike glycoprotein
cryo-EM structure of SARS-CoV-2 spike in complex with Fab 15033-7, two RBDs bound
 0.63 99.26 0.95 1-1211 EM 0.00 hetero-3-2-2-mer 25 x NAG, 7 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kxj.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxj.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxj.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric
 0.61 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 7 x NAG, 2 x NAG-NAG-BMA, 1 x NAG-NAG HHblits 0.61
7kxk.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7kxk.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7kxk.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation
 0.62 99.26 0.95 1-1211 EM 0.00 hetero-3-3-3-mer 16 x NAG, 12 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
8a94.1.A
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
 0.69 99.09 0.95 1-1212 EM 0.00 hetero-3-3-3-mer 43 x NAG, 7 x NAG-NAG HHblits 0.61
8a94.1.B
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
 0.68 99.09 0.95 1-1212 EM 0.00 hetero-3-3-3-mer 43 x NAG, 7 x NAG-NAG HHblits 0.61
8a94.1.C
SARS-CoV2 Spike in 2-up conformation in complex with Fab47
SARS CoV2 Spike in the 2-up state in complex with Fab47
 0.70 99.09 0.95 1-1212 EM 0.00 hetero-3-3-3-mer 43 x NAG, 7 x NAG-NAG HHblits 0.61
7mxp.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.62 99.67 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7mxp.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.61 99.67 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7mxp.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody LP5 Fab in complex with SARS-CoV-2 S2P spike
 0.64 99.67 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 28 x NAG, 3 x NAG-NAG-BMA-MAN-NAG-NAG-BMA-FUC, 3 x NAG-NAG, 1 x NAG-NAG-BMA HHblits 0.62
7r8n.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
 0.62 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 4 x NAG-NAG HHblits 0.61
7r8n.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
 0.62 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 4 x NAG-NAG HHblits 0.61
7r8n.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C051
 0.62 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 27 x NAG, 4 x NAG-NAG HHblits 0.61
7r8m.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.64 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8m.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.61 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8m.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C032
 0.62 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 22 x NAG, 4 x NAG-NAG, 1 x NAG-NAG-FUC HHblits 0.61
7r8o.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
 0.70 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUC HHblits 0.61
7r8o.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
 0.70 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUC HHblits 0.61
7r8o.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C548
 0.70 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 26 x NAG, 5 x NAG-NAG, 1 x NAG-NAG-FUC, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-FUC HHblits 0.61
7rkv.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7rkv.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7rkv.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody C118 (State 1)
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7s0d.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.71 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0c.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.70 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7s0d.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.71 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0d.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-014
 0.69 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7s0e.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S1 subunit in complex with antibody N-612-004
 0.38 99.17 0.95 1-1213 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7s0c.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7s0c.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with neutralizing antibody N-612-017
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-2-2-mer 19 x NAG, 6 x NAG-NAG HHblits 0.61
7sc1.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7sc1.1.D
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7sc1.1.G
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, R40-1G8
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7uar.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.67 99.17 0.95 1-1213 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7uap.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.66 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7uaq.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 NTD in complex with C1520, local refinement
 0.07 99.17 0.95 1-1213 EM 0.00 hetero-1-1-1-mer 4 x NAG, 3 x NAG-NAG HHblits 0.61
7uap.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.64 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7uar.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.64 99.17 0.95 1-1213 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
7uap.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1520
 0.66 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 35 x NAG, 12 x NAG-NAG HHblits 0.61
7uar.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the neutralizing antibody Fab fragment, C1717
 0.66 99.17 0.95 1-1213 EM 3.50 hetero-3-3-3-mer 27 x NAG, 6 x NAG-NAG, 1 x NAG-NAG-BMA-FUC HHblits 0.61
8dad.1.C
Spike glycoprotein
SARS-CoV-2 receptor binding domain in complex with AZ090 Fab
 0.04 99.17 0.95 1-1213 EM 0.00 hetero-1-1-1-mer 2 x NAG-NAG HHblits 0.61
7uz9.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 42 x NAG HHblits 0.61
7uz4.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG HHblits 0.61
7uz5.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
 0.69 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 48 x NAG HHblits 0.61
7uz7.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG, 3 x NAG-NAG HHblits 0.61
7uz7.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG, 3 x NAG-NAG HHblits 0.61
7uz7.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-31
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG, 3 x NAG-NAG HHblits 0.61
7uz6.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
 0.66 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7uz9.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 42 x NAG HHblits 0.61
7uza.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 34 x NAG, 2 x NAG-NAG HHblits 0.61
7uz5.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
 0.69 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 48 x NAG HHblits 0.61
7uz9.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-34
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 42 x NAG HHblits 0.61
7uza.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
 0.65 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 34 x NAG, 2 x NAG-NAG HHblits 0.61
7uz6.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7uz4.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG HHblits 0.61
7uza.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, HSW-1
 0.66 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 34 x NAG, 2 x NAG-NAG HHblits 0.61
7uz5.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-6
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-1-1-mer 48 x NAG HHblits 0.61
7uz6.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-28
 0.67 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 39 x NAG HHblits 0.61
7uz4.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S 6P trimer in complex with the mouse antibody Fab fragment, M8a-3
 0.68 99.17 0.95 1-1213 EM 0.00 hetero-3-3-3-mer 45 x NAG, 3 x NAG-NAG HHblits 0.61
7uzb.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 S S1 doamin in complex with the mouse antibody Fab fragment, HSW-2
 0.36 99.17 0.95 1-1213 EM 0.00 hetero-1-1-1-mer 4 x NAG HHblits 0.61
6zge.1.A
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.67 0.95 1-1208 EM 0.00 homo-trimer 21 x NAG, 30 x NAG-NAG HHblits 0.62
6zge.1.B
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.67 0.95 1-1208 EM 0.00 homo-trimer 21 x NAG, 30 x NAG-NAG HHblits 0.62
6zge.1.C
Spike glycoprotein
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation
 0.71 99.67 0.95 1-1208 EM 0.00 homo-trimer 21 x NAG, 30 x NAG-NAG HHblits 0.62
7nt9.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 24 x NAG, 30 x NAG-NAG HHblits 0.62
7nt9.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 24 x NAG, 30 x NAG-NAG HHblits 0.62
7nt9.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (closed conformation)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 24 x NAG, 30 x NAG-NAG HHblits 0.62
7nta.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
7nta.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.B
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.65 99.67 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.64 99.67 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7ntc.1.A
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain bound to P008_056 Fab
 0.64 99.67 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 2 x BLA, 29 x NAG, 25 x NAG-NAG HHblits 0.62
7nta.1.C
Spike glycoprotein
Trimeric SARS-CoV-2 spike ectodomain in complex with biliverdin (one RBD erect)
 0.66 99.67 0.95 1-1208 EM 0.00 homo-trimer 3 x BLA, 27 x NAG, 25 x NAG-NAG HHblits 0.62
7zbu.1.A
Spike glycoprotein
CryoEM structure of SARS-CoV-2 spike monomer in complex with neutralising antibody P008_60
 0.39 99.67 0.95 1-1208 EM 0.00 hetero-1-1-1-mer 8 x NAG, 1 x 3Q9 HHblits 0.62
7ns6.1.G
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ns6.1.H
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ns6.1.I
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.72 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ns6.1.J
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ns6.1.K
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.70 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ns6.1.L
Spike glycoprotein,Fibritin
SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies
 0.71 99.01 0.95 1-1212 EM 0.00 hetero-6-6-mer 46 x NAG, 2 x NAG-NAG-BMA HHblits 0.61
7kdk.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdk.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdk.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kdl.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ke9.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7kdl.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ke9.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7kdl.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ke9.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7ke4.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke4.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke4.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-class)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke6.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke6.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke6.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke7.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke7.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke7.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3-RBD-down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7kea.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.68 99.67 0.95 1-1208 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.62
7kea.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.66 99.67 0.95 1-1208 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.62
7kea.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub classification)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 34 x NAG, 12 x NAG-NAG HHblits 0.62
7keb.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.67 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7keb.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.64 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7keb.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.65 99.67 0.95 1-1208 EM 0.00 homo-trimer 35 x NAG, 12 x NAG-NAG HHblits 0.62
7kec.1.A
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.63 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.62
7kec.1.B
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.62 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.62
7kec.1.C
Spike glycoprotein
SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification)
 0.65 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 12 x NAG-NAG HHblits 0.62
7ke8.1.A
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke8.1.C
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.69 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
7ke8.1.B
Spike glycoprotein
SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G sub-classification)
 0.70 99.67 0.95 1-1208 EM 0.00 homo-trimer 33 x NAG, 15 x NAG-NAG HHblits 0.62
8c8p.1.B
Spike glycoprotein,SARS-CoV-2 spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement)
 0.01 99.01 0.95 1-1212 EM 0.00 hetero-1-1-mer HHblits 0.61
7ej5.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.64 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.61
7f63.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-45 (Focused refinement of S-RBD and chAb-45 region)
 0.03 99.59 0.95 1-1207 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7ej4.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.63 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.61
7ej4.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.61
7f62.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody chAb-25 (Focused refinement of S-RBD and chAb-25 region)
 0.03 99.59 0.95 1-1207 EM 0.00 hetero-1-1-1-mer HHblits 0.61
7ej4.1.A
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25
 0.64 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 21 x NAG, 27 x NAG-NAG HHblits 0.61
7ej5.1.B
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.64 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.61
7ej5.1.C
Spike glycoprotein
Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45
 0.64 99.59 0.95 1-1207 EM 0.00 hetero-3-3-3-mer 24 x NAG, 24 x NAG-NAG HHblits 0.61
7e5r.1.G
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
 0.65 99.59 0.95 1-1208 EM 3.60 hetero-3-3-3-3-3-3-… 15 x NAG-NAG HHblits 0.61
7e5r.1.N
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
 0.65 99.59 0.95 1-1208 EM 3.60 hetero-3-3-3-3-3-3-… 15 x NAG-NAG HHblits 0.61
7e5r.1.U
Spike glycoprotein
SARS-CoV-2 S trimer with three-antibody cocktail complex
 0.65 99.59 0.95 1-1208 EM 3.60 hetero-3-3-3-3-3-3-… 15 x NAG-NAG HHblits 0.61
7e5s.1.B
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.62 99.59 0.95 1-1208 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.61
7e5s.1.A
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.62 99.59 0.95 1-1208 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.61
7e5s.1.C
Spike glycoprotein
SARS-CoV-2 S trimer with four-antibody cocktail complex
 0.63 99.59 0.95 1-1208 EM 3.60 hetero-3-2-2-2-2-3-… 12 x NAG-NAG HHblits 0.61
7fb0.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb0.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb0.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in closed state
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb1.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
 0.63 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb1.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
 0.63 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb1.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD open state
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb3.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb4.1.A
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
 0.53 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb3.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
 0.55 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb4.1.B
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
 0.54 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb3.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in one-RBD weak state after CTSL-treatment
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7fb4.1.C
Spike glycoprotein
SARS-CoV-2 spike protein in two-RBD weak state after CTSL-treatment
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7e3k.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.67 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 22 x NAG HHblits 0.61
7e3l.1.A
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.69 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 20 x NAG HHblits 0.61
7e3l.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.69 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 20 x NAG HHblits 0.61
7e3k.1.C
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.67 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 22 x NAG HHblits 0.61
7e3l.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.69 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 20 x NAG HHblits 0.61
7e3k.1.B
Spike glycoprotein
Ultrapotent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
 0.67 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 22 x NAG HHblits 0.61
7ws0.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7ws1.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.59 0.95 1-1192 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7ws1.1.C
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.59 0.95 1-1192 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7ws0.1.B
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7ws0.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.71 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7ws1.1.A
Spike glycoprotein
Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development
 0.70 99.59 0.95 1-1192 EM 0.00 hetero-3-4-4-mer 30 x NAG, 18 x NAG-NAG HHblits 0.61
7v26.1.B
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.65 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7v26.1.A
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.66 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7v26.1.C
Spike glycoprotein
XG005-bound SARS-CoV-2 S
 0.65 99.59 0.95 1-1192 EM 0.00 hetero-3-3-3-mer 45 x NAG HHblits 0.61
7y7j.1.A
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
 0.68 99.59 0.95 1-1192 EM 4.80 hetero-3-1-1-mer 26 x NAG, 15 x NAG-NAG HHblits 0.61
7y7j.1.B
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
 0.68 99.59 0.95 1-1192 EM 4.80 hetero-3-1-1-mer 26 x NAG, 15 x NAG-NAG HHblits 0.61
7y7j.1.C
Spike glycoprotein
SARS-CoV-2 S trimer in complex with 1F Fab
 0.68 99.59 0.95 1-1192 EM 4.80 hetero-3-1-1-mer 26 x NAG, 15 x NAG-NAG HHblits 0.61
7akd.1.A
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.61
7akd.1.B
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.61
7akd.1.C
Spike glycoprotein
Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 25 x NAG, 3 x FUC, 2 x MAN, 10 x NAG-NAG, 3 x NAG-NAG-BMA, 1 x NAG-NAG-BMA-MAN-MAN, 1 x NAG-NAG-BMA-FUC, 1 x NAG-NAG-BMA-MAN-MAN-FUC, 1 x MAN-MAN HHblits 0.61
7oan.1.A
Spike glycoprotein
Nanobody C5 bound to Spike
 0.72 99.59 0.95 1-1208 EM 3.00 hetero-3-3-mer 36 x NAG, 15 x NAG-NAG HHblits 0.61
7oan.1.B
Spike glycoprotein
Nanobody C5 bound to Spike
 0.72 99.59 0.95 1-1208 EM 3.00 hetero-3-3-mer 36 x NAG, 15 x NAG-NAG HHblits 0.61
7oan.1.C
Spike glycoprotein
Nanobody C5 bound to Spike
 0.72 99.59 0.95 1-1208 EM 3.00 hetero-3-3-mer 36 x NAG, 15 x NAG-NAG HHblits 0.61
7ddd.1.B
Spike glycoprotein
SARS-Cov2 S protein at close state
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7ddd.1.C
Spike glycoprotein
SARS-Cov2 S protein at close state
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7ddd.1.A
Spike glycoprotein
SARS-Cov2 S protein at close state
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7df3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
 0.68 99.59 0.95 1-1208 EM 0.00 homo-trimer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7df3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
 0.68 99.59 0.95 1-1208 EM 0.00 homo-trimer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7df3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-closed
 0.68 99.59 0.95 1-1208 EM 0.00 homo-trimer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7ddn.1.C
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7ddn.1.A
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7dd8.1.C
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-1-1-3-mer HHblits 0.61
7dd8.1.D
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-1-1-3-mer HHblits 0.61
7dd8.1.E
Spike glycoprotein
S-3C1-F1 structure, one RBD is up and two RBDs are down, the up RBD binds with a 3C1 fab
 0.62 99.59 0.95 1-1208 EM 0.00 hetero-1-1-3-mer HHblits 0.61
7ddn.1.B
Spike glycoprotein
SARS-Cov2 S protein at open state
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7dk3.1.C
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.66 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7dk3.1.B
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7dk3.1.A
Spike glycoprotein
SARS-CoV-2 S trimer, S-open
 0.67 99.59 0.95 1-1208 EM 0.00 homo-trimer HHblits 0.61
7df4.1.D
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.61
7df4.1.C
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.61
7df4.1.B
Spike glycoprotein
SARS-CoV-2 S-ACE2 complex
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer 36 x NAG, 18 x NAG-NAG HHblits 0.61
7dd2.1.B
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dk5.1.E
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7dk5.1.B
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7dd2.1.A
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dk6.1.C
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dk7.1.I
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dk7.1.D
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dk4.1.D
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dcc.1.D
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dk6.1.A
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dcx.1.H
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dk5.1.A
Spike glycoprotein
S-2H2-F1 structure, one RBD is up and two RBDs are down, only up RBD binds with a 2H2 Fab
 0.62 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7dk4.1.C
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dcc.1.H
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dcx.1.C
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dd2.1.E
Spike glycoprotein
S-3C1-F2 structure, two RBDs are up and one RBD is down, the two up RBD bind with a 3C1 fab.
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dk6.1.B
Spike glycoprotein
S-2H2-F2 structure, two RBDs are up and one RBD is down, each up RBD binds with a 2H2 Fab.
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer HHblits 0.61
7dk7.1.C
Spike glycoprotein
S-2H2-F3b structure, three RBDs are up and each RBD binds with a 2H2 Fab.
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dcc.1.G
Spike glycoprotein
S-3C1-F3b structure, all the three RBDs are in the up conformation and each of them associates with a 3C1 Fab
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dcx.1.I
Spike glycoprotein
S-3C1-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 3C1 fab.
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7dk4.1.E
Spike glycoprotein
S-2H2-F3a structure, two RBDs are up and one RBD is down, each RBD binds with a 2H2 Fab.
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7v2a.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
 0.70 99.59 0.95 1-1208 EM 3.40 hetero-3-3-3-mer 24 x NAG HHblits 0.61
7v2a.1.E
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
 0.70 99.59 0.95 1-1208 EM 3.40 hetero-3-3-3-mer 24 x NAG HHblits 0.61
7v2a.1.D
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with XG014 Fab
 0.70 99.59 0.95 1-1208 EM 3.40 hetero-3-3-3-mer 24 x NAG HHblits 0.61
7jwb.1.B
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer HHblits 0.61
7jwb.1.C
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer HHblits 0.61
7kqe.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7m7b.1.A
Spike glycoprotein
SARS-CoV-2 Spike:Fab 3D11 complex focused refinement
 0.04 99.59 0.95 1-1208 EM 0.00 hetero-1-1-1-mer 2 x NAG HHblits 0.61
7m71.1.A
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.05 99.59 0.95 1-1208 EM 0.00 hetero-2-1-1-mer 4 x NAG HHblits 0.61
7kqb.1.C
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 23 x NAG HHblits 0.61
7kqb.1.B
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 23 x NAG HHblits 0.61
7kqe.1.E
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7kqe.1.D
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 3D11 complex
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer HHblits 0.61
7m71.1.B
Spike glycoprotein
SARS-CoV-2 Spike:5A6 Fab complex I focused refinement
 0.04 99.59 0.95 1-1208 EM 0.00 hetero-2-1-1-mer 4 x NAG HHblits 0.61
7kqb.1.A
Spike glycoprotein
SARS-CoV-2 spike glycoprotein:Fab 5A6 complex I
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-2-2-mer 23 x NAG HHblits 0.61
7jwb.1.D
Spike glycoprotein
SARS CoV2 Spike ectodomain with engineered trimerized VH binder
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-1-3-mer HHblits 0.61
8dv1.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432
 0.03 99.59 0.95 1-1208 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.61
8dv2.1.A
Spike glycoprotein
SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293
 0.04 99.59 0.95 1-1208 EM 0.00 hetero-1-1-mer 7 x NAG HHblits 0.61
8heb.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
8heb.1.C
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
8heb.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 1 conformation
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
8hec.1.B
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
8hec.1.C
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
8hec.1.A
Spike glycoprotein
SARS-CoV-2 Spike trimer in complex with RmAb 9H1 Fab in the class 2 conformation
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 27 x NAG, 17 x NAG-NAG HHblits 0.61
7wcd.1.A
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 33 x NAG HHblits 0.61
7wcd.1.D
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 33 x NAG HHblits 0.61
7wcd.1.G
Spike glycoprotein
Cryo EM structure of SARS-CoV-2 spike in complex with TAU-2212 mAbs in conformation 4
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 33 x NAG HHblits 0.61
7kni.1.B
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.61
7kni.1.C
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.61
7kmz.1.B
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.61
6zxn.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.73 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.61
7a29.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.61
7a29.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.72 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.61
7a29.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 45 x NAG, 8 x NAG-NAG HHblits 0.61
6vsb.1.B
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.70 99.59 0.95 1-1208 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.61
6zxn.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.72 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.61
6xey.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMA HHblits 0.61
6xey.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMA HHblits 0.61
6xey.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-4
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 7 x NAG-NAG, 3 x NAG-NAG-BMA, 2 x NAG-BMA HHblits 0.61
6vsb.1.A
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.69 99.59 0.95 1-1208 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.61
6vsb.1.C
Spike glycoprotein
Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up
 0.69 99.59 0.95 1-1208 EM 0.00 homo-trimer 27 x NAG, 17 x NAG-NAG HHblits 0.61
7ljr.1.B
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7ljr.1.A
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7ljr.1.C
Spike glycoprotein
SARS-CoV-2 Spike Protein Trimer bound to DH1043 fab
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer HHblits 0.61
7l57.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.61
7kkk.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7kkk.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7kkk.1.E
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 30 x NAG, 12 x NAG-NAG HHblits 0.61
7l57.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.60 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.61
7l58.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.61
7kkl.1.A
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
7kkl.1.E
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
7kkl.1.C
Spike glycoprotein
SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 27 x NAG, 18 x NAG-NAG HHblits 0.61
7l57.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15
 0.61 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 31 x NAG, 7 x NAG-NAG, 1 x NAG-NAG-BMA-MAN-NAG, 1 x NAG-NAG-BMA-NAG HHblits 0.61
7l58.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.61
7l58.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 33 x NAG, 4 x NAG-NAG HHblits 0.61
7b18.1.A
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.61
7b18.1.B
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.61
7b18.1.C
Spike glycoprotein
SARS-CoV-spike bound to two neutralising nanobodies
 0.71 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 42 x NAG, 1 x NAG-NAG HHblits 0.61
7l2d.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7l2d.1.D
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7l2e.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7l2e.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7l2e.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 24 x NAG-NAG HHblits 0.61
7l2f.1.B
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7l2f.1.C
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7l2d.1.E
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 34 x NAG, 17 x NAG-NAG, 3 x NAG-NAG-BMA HHblits 0.61
7l2f.1.A
Spike glycoprotein
Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 36 x NAG, 16 x NAG-NAG, 2 x NAG-NAG-BMA HHblits 0.61
7ksg.1.C
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.61
7ksg.1.A
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.69 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.61
7ksg.1.B
Spike glycoprotein
SARS-CoV-2 spike in complex with nanobodies E
 0.70 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 51 x NAG HHblits 0.61
7ls9.1.D
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAG HHblits 0.61
7ls9.1.G
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAG HHblits 0.61
7ls9.1.A
Spike glycoprotein
Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-3-3-mer 30 x NAG, 3 x NAG-NAG-BMA, 18 x NAG-NAG HHblits 0.61
7lss.1.A
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.52 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.61
7lss.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.68 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.61
7lss.1.C
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-7
 0.52 99.59 0.95 1-1208 EM 0.00 hetero-3-1-1-mer 30 x NAG, 6 x NAG-NAG HHblits 0.61
7kne.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.62 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.61
7kms.1.B
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.66 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.61
7knh.1.B
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.61
7kne.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.61
7knb.1.B
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.61
7kms.1.D
Spike glycoprotein
Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 55 x NAG, 8 x NAG-NAG HHblits 0.61
7knh.1.D
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.63 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.61
7kmz.1.D
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.61
6zxn.1.B
Spike glycoprotein
Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
 0.73 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 39 x NAG, 12 x NAG-NAG HHblits 0.61
7knh.1.A
Spike glycoprotein
Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 48 x NAG, 4 x NAG-NAG HHblits 0.61
7kmz.1.A
Spike glycoprotein
Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4
 0.67 99.59 0.95 1-1208 EM 0.00 hetero-3-2-mer 53 x NAG, 4 x NAG-NAG HHblits 0.61
7knb.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.65 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.61
7kne.1.A
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5
 0.64 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 44 x NAG, 6 x NAG-NAG HHblits 0.61
7knb.1.C
Spike glycoprotein
Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4
 0.62 99.59 0.95 1-1208 EM 0.00 hetero-3-1-mer 46 x NAG, 5 x NAG-NAG HHblits 0.61
7kni.1.A
Spike glycoprotein
Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5
 0.62 99.59 0.95 1-1208 EM 0.00 hetero-3-3-mer 56 x NAG, 6 x NAG-NAG HHblits 0.61